Medicared For All Logo

Henna Malik in Sugar Land, Texas

Home Texas Sugar Land

Henna Malik has Medical Oncology as her primary medical specialty. Their primary office is: 1350 1st Colony Blvd in Sugar Land, Texas.

They're a part of the: Texas Oncology Pa medical group which has around 833 members. You can call their office at 281-296-0365 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2004 (around 20 years of experience). They are listed as doing telehealth appointments.


Henna M Malik Office Phone and Directions

Henna Malik
Texas Oncology Pa
1350 1st Colony Blvd
Sugar Land, Texas 77479
281-296-0365


Patient Ratings
Please rate your experience with Henna Malik below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 281-296-0365


Enter a starting address:


Healthcare Info for Henna Malik

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2004
The Primary Medical Specialty for Henna Malik is listed as: Medical Oncology
Approximate Years of Experience: 20
PAC (PECOS ID)#: 4183800410
NPI #: 1003099813
NPI Created On: 12/14/2007
NPI Last Updated Listed as: 04/13/2018
Primary Taxonomy Code: 207R00000X
License Number:
01064564A
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • FirstCare Health Plans
  • Humana
  • Community Health Choice
  • Molina Marketplace
  • Celtic Insurance Company
  • CHRISTUS Health Plan
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Ct scan chest with contrast
  3. Microscopic examination for white blood cells with manual cell count
  4. Complete blood cell count (red cells, white blood cell, platelets), automated test
  5. Complete blood cell count (red cells, white blood cell, platelets), automated test
  6. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  7. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  9. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  10. Infusion of chemotherapy into a vein up to 1 hour
  11. Infusion of chemotherapy into a vein
  12. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  13. New patient office or other outpatient visit, typically 45 minutes
  14. New patient office or other outpatient visit, typically 60 minutes
  15. Established patient office or other outpatient visit, typically 15 minutes
  16. Established patient office or other outpatient, visit typically 25 minutes
  17. Established patient office or other outpatient, visit typically 40 minutes
  18. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
  19. Injection, darbepoetin alfa, 1 microgram (non-esrd use)
  20. Injection, denosumab, 1 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819186015

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803000431

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175085

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175141

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175189

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $85

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175211

Being Disputed:: No

Product Related: No


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175265

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832175281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 783610635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $9

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Travel and Lodging City: Beaumont

Travel and Lodging State: TX

Travel and Lodging Country: United States

Record ID:: 783610641

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Medical Oncology Professionals in Sugar Land

16605 Southwest Fwy
Sugar-land, TX
Oncology Consultants, P. A..

16655 Southwest Fwy
Sugar-land, TX
Tmh Physician Associates Pllc

16605 Sw Fwy 410
Sugar-land, TX
Tmh Physician Associates Pllc

16605 Southwest Fwy 400 Mob3
Sugar-land, TX
Tmh Physician Associates Pllc

16605 Southwest Fwy
Sugar-land, TX
Tmh Physician Associates Pllc

1350 1st Colony Blvd
Sugar-land, TX
Texas Oncology Pa

Providers in Texas Oncology Pa

1.Mirna Abboud

501 W Medical Ctr Blvd
Webster Tx 77598-4219
Texas Oncology Pa
Radiation Oncology

2.Seyed Abedi

501 W Medical Ctr Blvd
Webster Tx 77598-4219
Texas Oncology Pa
Hematology/oncology

3.Seyed Abedi

1401 Medical Pkwy
Cedar Park Tx 78613-5026
Texas Oncology Pa
Hematology/oncology

4.Laith Abushahin

3705 W 15th St
Plano Tx 75075-7753
Texas Oncology Pa
Medical Oncology

5.Laith Abushahin

3410 Worth St
Dallas Tx 75246-2092
Texas Oncology Pa
Medical Oncology

6.Maria Acevedo

7848 Gateway Blvd E
El Paso Tx 79915-1815
Texas Oncology Pa
Nurse Practitioner

View all 833 members of Texas Oncology Pa medical group